Financial Architects (New Jersey)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $245K | Hold |
1,711
| – | – | 0.04% | 289 |
|
|
2023
Q1 | $237K | Buy |
1,711
+125
| +8% | +$16.8K | 0.04% | 288 |
|
|
2022
Q4 | $215K | Buy |
+1,586
| New | +$199K | 0.04% | 310 |
|
|
2022
Q3 | – | Sell |
-1,536
| Closed | -$203K | – | 310 |
|
|
2022
Q2 | $203K | Sell |
1,536
-150
| -9% | -$19.7K | 0.26% | 56 |
|
|
2022
Q1 | $224K | Sell |
1,686
-48
| -3% | -$5.76K | 0.03% | 312 |
|
|
2021
Q4 | $202K | Hold |
1,734
| – | – | 0.03% | 328 |
|
|
2021
Q3 | $208K | Buy |
1,734
+1
| +0.1% | +$116 | 0.03% | 317 |
|
|
2021
Q2 | $208K | Buy |
+1,733
| New | +$190K | 0.03% | 324 |
|
|
2020
Q3 | – | Sell |
-1,529
| Closed | -$162K | – | 312 |
|
|
2020
Q2 | $162K | Hold |
1,529
| – | – | 0.04% | 271 |
|
|
2020
Q1 | $137K | Hold |
1,529
| – | – | 0.04% | 269 |
|
|
2019
Q4 | $152K | Hold |
1,529
| – | – | 0.03% | 272 |
|
|
2019
Q3 | $136K | Hold |
1,529
| – | – | 0.03% | 284 |
|
|
2019
Q2 | $126K | Sell |
1,529
-183
| -11% | -$14.3K | 0.02% | 332 |
|
|
2019
Q1 | $138K | Sell |
1,712
-828
| -33% | -$65.3K | 0.02% | 385 |
|
|
2018
Q4 | $193K | Buy |
2,540
+1,110
| +78% | +$86.7K | 0.04% | 268 |
|
|
2018
Q3 | $113K | Sell |
1,430
-647
| -31% | -$48.9K | 0.02% | 436 |
|
|
2018
Q2 | $146K | Buy |
2,077
+84
| +4% | +$6.04K | 0.03% | 330 |
|
|
2018
Q1 | $140K | Buy |
1,993
+875
| +78% | +$60.6K | 0.03% | 376 |
|
|
2017
Q4 | $77K | Sell |
1,118
-214
| -16% | -$14.4K | 0.01% | 558 |
|
|
2017
Q3 | $90K | Buy |
1,332
+120
| +10% | +$7.58K | 0.02% | 518 |
|
|
2017
Q2 | $83K | Buy |
1,212
+247
| +26% | +$16.1K | 0.01% | 527 |
|
|
2017
Q1 | $60K | Buy |
965
+204
| +27% | +$11.9K | 0.01% | 605 |
|
|
2016
Q4 | $41K | Sell |
761
-163
| -18% | -$9.26K | 0.01% | 615 |
|
|
2016
Q3 | $61K | Buy |
924
+519
| +128% | +$33.9K | 0.02% | 516 |
|
|
2016
Q2 | $24K | Hold |
405
| – | – | 0.01% | 728 |
|
|
2016
Q1 | $23K | Buy |
+405
| New | +$24.3K | 0.01% | 559 |
|
|
2015
Q3 | – | Sell |
-88
| Closed | – | – | 266 |
|
|
2015
Q2 | $0 | Buy |
+88
| New | +$6.03K | ﹤0.01% | 1224 |
|
|
2015
Q1 | – | Sell |
-88
| Closed | -$6K | – | 932 |
|
|
2014
Q4 | $6K | Sell |
88
-235
| -73% | -$16.8K | ﹤0.01% | 780 |
|
|
2014
Q3 | $10K | Buy |
323
+151
| +88% | +$11.1K | ﹤0.01% | 596 |
|
|
2014
Q2 | $13K | Buy |
+172
| New | +$12.4K | 0.01% | 575 |
|
|
2013
Q4 | – | Sell |
-1,384
| Closed | -$73K | – | 185 |
|
|
2013
Q3 | $73K | Buy |
1,384
+229
| +20% | +$11.5K | 0.05% | 214 |
|
|
2013
Q2 | $54K | Buy |
+1,155
| New | +$58.8K | 0.04% | 233 |
|
Other funds holding AZN
Financial Architects (New Jersey)'s AZN Position: Q2 2023 in Review
Financial Architects (New Jersey) held its AstraZeneca (AZN) position steady in Q2 2023 at 1,711 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #289.
Financial Architects (New Jersey) first reported a position in AZN in Q2 2013 and has held it in 32 quarters since. 1,092 funds tracked by Wall St. Rank hold AZN as of Q2 2023.
- Financial Architects (New Jersey) held 1,711 shares of AstraZeneca worth $245K as of Q2 2023.
- Financial Architects (New Jersey) left its AstraZeneca share count unchanged in Q2 2023.
- AstraZeneca made up 0.04% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #289 holding.
- Financial Architects (New Jersey) first reported a position in AstraZeneca in Q2 2013 and has held it in 32 quarters since.
- 1,092 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.
Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.